OneMedNet regains compliance with Nasdaq's minimum bid price rule
Nasdaq notified the company on October 13, 2026 that its stock had met the $1.00 minimum closing bid price requirement for 10 consecutive business days.
OneMedNet Corporation disclosed in an 8-K filing that it had resolved a Nasdaq listing deficiency tied to its stock price. The company had previously disclosed that on April 14, 2026, it received a letter from Nasdaq's Listing Qualifications staff stating it was not in compliance with the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2), with a grace period to regain compliance set for October 12, 2026.1
On October 13, 2026, the company received written notice from Nasdaq staff indicating it had regained compliance with the Bid Price Rule, based on the stock's closing bid price staying at or above $1.00 per share for 10 consecutive business days from September 29, 2026 through October 12, 2026.1 As a result, the company said it has regained compliance with Nasdaq Listing Rule 5550(a)(2), and the matter is now closed.1
The filing identifies OneMedNet's listed securities as Common Stock, par value $0.0001 per share, trading under the symbol ONMD, and Redeemable Warrants, each lot of 10 exercisable for one share of Common Stock at an exercise price of $115.00 per share, trading under the symbol ONMDW, both on The Nasdaq Stock Market LLC.1
The report was signed by Aaron Green, identified in the filing as Chief Executive Officer, and dated October 14, 2026.
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.